Publication Year

Rose AJ, Sacks NC, Deshpande AP, Griffin SY, Cabral HJ, Kazis LE. 2008. Single-change items do not measure change in quality of life. J Clin Epidemiol 61(6):603–608.

Makris SL, Thompson CM, Euling SY, Selevan SG, Sonawane B. 2008. A lifestage-specific spproach to hazard and dose-response characterization for children’s health risk assessment. Birth Defects Res B 83(6):530–546; doi: 10.1002/bdrb.20176.

Staskal DF. 2008. Roundtable: Case study on the risks and benefits of DecaBDE, a major brominated flame retardant. Presented at the Society of Toxicology 47th Annual Meeting, Seattle, WA, March 2008.

Gearhart JM, Covington TR, Robinson PJ, Whalley CE, McGuire JM, Evans RA, et al. Simulation of VX exposure in multiple species by means of a physiologically based pharmacokinetic/pharmacodynamic model. Poster presented at the Bioscience Review Conference, Baltimore, MD, May 2008.

Bailey WH, Wagner ME. 2008. IARC evaluation of ELF magnetic fields: Public understanding of the 0.4-lT exposure metric. J Exposure Sci Environ Epidemiol 18(3):233–235; doi: 10.1038/sj.jes.7500643.

Richardson VM, Staskal DF, Ross DG, Diliberto JJ, Devito MJ, Birnbaum LS. 2008. Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener. Toxicol Appl Pharmacol 226(3):244-250; doi: 10.1016/j.taap.2007.09.015.

Staskal DF, Tachovsky JA, Harris MA, Haws LC. 2008. Preliminary evaluation of human health risk associated with exposure to PBDEs in the United States. Presented at Dioxin 2008, August 17-22, Birmingham, England.

Scott LLF, Harris MA, Unice KM, Scott P, Nguyen LM, Haws LC, Paustenbach D. 2008. Addendum to: Evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001-2002 National Health and Nutrition Examination Survey of the United States population. J Exp Sci Env Epidemiol 18(5):524-532; doi: 10.1038/jes.2008.10.

Tachovsky JA, Harris MA, Staskal DF, Scott LF, Luksemburg WJ, Paustenbach DP, Haws LC. Analysis of fish tissue concentrations of dioxins and furans using principal components analysis. Presented at Dioxin 2008, Birmingham, England, August 2008.

Stokes W, Allen D, Burns T, Choksi N, Matheson, J, Jacobs, Tice, R. Performance characteristics of the local lymph node assay (llna) limit dose procedure. Poster presented at Society of Toxicology 47th Annual Meeting, Seattle, WA, March 2008

Scott PK, Proctor D. 2008. Soil suspension/dispersion modeling methods for estimating health-based soil cleanup levels of hexavalent chromium at chromite ore processing residue sites. J Air Waste Manag Assoc 58(3):384-403; doi: 10.3155/1047-3289.58.3.384.

Tachovsky JA, Staskal DF, Harris MA, Scott LF, Luksemburg WJ, Paustenbach DP, Haws LC. 2008. Principal components analysis of PBDE concentrations in fish tissue from southern Mississippi. Presented at Dioxin 2008, August 17-22, Birmingham, England.

Hinerman J. Crystallographic and small angle scattering studies of the bacteriophage T4 replication complex. Invited presentation to American Crystallographic Association Annual Meeting, Knoxville, TN, June 2008.

Staskal DF, Scott LLF, Haws LC, Luksemburg WJ, Birnbaum LS, Nguyen LM, Urban JD, Williams ES, Paustenbach DJ, Harris MA. 2008. Assessment of polybrominated diphenyl ether exposures and health risks associated with consumption of southern Mississippi catfish. Environ Sci Technol 42(17):6755-6761; doi: 10.1021/es800613k.

Urban JD, Haws LC, Staskal DF, Scott LF, Scott PS, Tachovsky AT, Unice KM, Harris MA. A framework for evaluating serum dioxin data derived from biomonitoring studies. Presented at Dioxin 2008, Birmingham, England, August 17-22 2008.

Subramaniam RP, Chen C, Crump KS, Devoney D, Fox JF, Portier CJ, Schlosser PM, Thompson CM, White P. 2008. Uncertainties in biologically-based modeling of formaldehyde-induced respiratory cancer risk: Identification of key issues. Risk Analysis 28(4):907–923; doi: 10.1111/j.1539-6924.2008.01083.x.

Thompson CM, Subramaniam RP, Grafström RC. 2008. Mechanistic and dose considerations for supporting adverse pulmonary physiology in response to formaldehyde. Toxicol Appl Pharmacol 233(3):355–359.

Thompson CM, Sonawane B, Barton HA, DeWoskin RS, Schlosser P, Lipscomb JC, Chiu W, Krishnan K. 2008. Approaches for applications of physiologically based pharmacokinetic models in risk assessment. J Toxicol Environ Health B 11(7):519–547; doi: 10.1080/10937400701724337.

Williams CW, Perry CS. Risk assessment for arsenic on indoor surfaces. Presented at the Society for Risk Analysis Annual Meeting, Boston, MA, December 2008.

DeSesso JM, Watson RE, Keen CL, Hazelden KP, Haws LC, Li AA. 2008. Analysis and integration of developmental neurotoxicity and ancillary data into risk assessment: A case study of dimethoate. J Toxicol Environ Health A 72(2):94-109; doi: 10.1080/15287390802477452.